Future Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report

The median survival of patients with idiopathic pulmonary fibrosis (IPF) continues to be approximately 3 years from the time of diagnosis, underscoring the lack of effective medical therapies for this disease. In the United States alone, approximately 40,000 patients die of this disease annually. In...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Blackwell, Timothy S., Tager, Andrew M., Borok, Zea, Moore, Bethany B., Schwartz, David A., Anstrom, Kevin J., Bar-Joseph, Ziv, Bitterman, Peter, Blackburn, Michael R., Bradford, William, Brown, Kevin K., Chapman, Harold A., Collard, Harold R., Cosgrove, Gregory P., Deterding, Robin, Doyle, Ramona, Flaherty, Kevin R., Garcia, Christine Kim, Hagood, James S., Henke, Craig A., Herzog, Erica, Hogaboam, Cory M., Horowitz, Jeffrey C., King, Talmadge E., Loyd, James E., Lawson, William E., Marsh, Clay B., Noble, Paul W., Noth, Imre, Sheppard, Dean, Olsson, Julie, Ortiz, Luis A., O’Riordan, Thomas G., Oury, Tim D., Raghu, Ganesh, Roman, Jesse, Sime, Patricia J., Sisson, Thomas H., Tschumperlin, Daniel, Violette, Shelia M., Weaver, Timothy E., Wells, Rebecca G., White, Eric S., Kaminski, Naftali, Martinez, Fernando J., Wynn, Thomas A., Thannickal, Victor J., Eu, Jerry P.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Thoracic Society 2014
Témata:
NHLBI Workshop
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3983890/
https://ncbi.nlm.nih.gov/pubmed/24160862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201306-1141WS
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky